· News

POELLATH advises NEOsphere Biotechnologies GmbH on Series A financing round of EUR 6 million

NEOsphere Biotechnologies GmbH (“NEOsphere”) has successfully concluded a EUR 6 million Series A financing round with Ventura Biomed Investors as lead investor.

NEOsphere is a biotech start-up based in Planegg near Munich, Germany, that has developed a specialized data analytics platform for the pharmaceutical field, opening up numerous new avenues in drug discovery.

Ventura Biomed Investors is a biotech VC investor whose focus is on early-stage life science companies developing breakthrough technologies and innovative therapies.

POELLATH advised NEOsphere on the financing round with the following Munich team:

Monika Goede
+49 (89) 24 24 0 - 228 call